Publications by authors named "Weibang Yu"

Claim this Profile
R
Repurposing Cardiac Glycosides to Potentiate CD47 Blockade through Calreticulin-mediated Phagocytic Effects for Lung Cancer Treatment.
Zi-Han Ye, Wei-Bang Yu, Mu-Yang Huang, Yan-Yan Chen, Le-Le Zhang

Adv Sci (Weinh)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual blockade of GSTK1 and CD47 improves macrophage-mediated phagocytosis on cancer cells.
Wei-Bang Yu, Zi-Han Ye, Jia-Jie Shi, Wei-Qing Deng, Jun Chen

Biochem Pharmacol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives.
Zi-Han Ye, Wei-Bang Yu, Mu-Yang Huang, Jun Chen, Jin-Jian Lu

Acta Pharm Sin B· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis" [Toxicology and Applied Pharmacology 324 (2017) 12-25].
Xupeng Bai, Weipeng Hong, Peiheng Cai, Yibei Chen, Chuncao Xu, Weibang Yu

Toxicol Appl Pharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer.
Wei-Bang Yu, Yu-Chi Chen, Can-Yu Huang, Zi-Han Ye, Wei Shi

Front Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of AHSA1 as a Potential Therapeutic Target for Breast Cancer: Bioinformatics Analysis and in vitro Studies.
Wei Shi, Lu Qi, Xiong-Bin You, Yu-Chi Chen, Yu-Lian Xu, Wei-Bang Yu

Curr Cancer Drug Targets· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regulation of CD47 expression by interferon-gamma in cancer cells.
Zi-Han Ye, Xiao-Ming Jiang, Mu-Yang Huang, Yu-Lian Xu, Yu-Chi Chen, Luo-Wei Yuan, Can-Yu Huang, Wei-Bang Yu

Transl Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of small-molecule inhibitors targeting CD47.
Wei-Bang Yu, Zi-Han Ye, Xiuping Chen, Jia-Jie Shi, Jin-Jian Lu

Drug Discov Today· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells.
Luo-Wei Yuan, Xiao-Ming Jiang, Yu-Lian Xu, Mu-Yang Huang, Yu-Chi Chen, Wei-Bang Yu

Phytomedicine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative pharmacokinetics and tissue distribution of cryptotanshinone, tanshinone IIA, dihydrotanshinone I, and tanshinone I after oral administration of pure tanshinones and liposoluble extract of Salvia miltiorrhiza to rats.
Daifei Wang, Weibang Yu, Lin Cao, Chuncao Xu, Guoyao Tan

Biopharm Drug Dispos· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of curcumin, tetrahydrocurcumin, quercetin, and paeoniflorin by UHPLC-MS/MS in rat plasma and its application to a pharmacokinetic study.
Weilan Yu, Dingsheng Wen, Dake Cai, Juntao Zheng, Haining Gan, Weibang Yu

J Pharm Biomed Anal· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influences of an NR1I2 polymorphism on heterogeneous antiplatelet reactivity responses to clopidogrel and clinical outcomes in acute ischemic stroke patients.
Yi-Bei Chen, Zi-Yi Zhou, Guo-Min Li, Can-Xing Xiao, Wei-Bang Yu

Acta Pharmacol Sin· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous determination of trimethylamine N-oxide, choline, betaine by UPLC-MS/MS in human plasma: An application in acute stroke patients.
Weibang Yu, Chuncao Xu, Guomin Li, Weipeng Hong, Ziyi Zhou, Yuanqi Zhao

J Pharm Biomed Anal· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses Cisplatin Resistance in Lung Cancer Cells via the Redox System.
Weipeng Hong, Peiheng Cai, Chuncao Xu, Di Cao, Weibang Yu

Front Pharmacol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis.
Xupeng Bai, Weipeng Hong, Peiheng Cai, Yibei Chen, Chuncao Xu, Weibang Yu

Toxicol Appl Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations of CYP3A4, NR1I2, CYP2C19 and P2RY12 polymorphisms with clopidogrel resistance in Chinese patients with ischemic stroke.
Rui Liu, Zi-Yi Zhou, Yi-Bei Chen, Jia-Li Li, Wei-Bang Yu, Yuan-Qi Zhao

Acta Pharmacol Sin· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis